MEDICINES BY DESIGN LTD

Dissolved Colchester

Wholesale of pharmaceutical goods

2 employees website.com
Wholesale of pharmaceutical goods
M

MEDICINES BY DESIGN LTD

Wholesale of pharmaceutical goods

Founded 5 Dec 2011 Dissolved Colchester, England 2 employees website.com
Wholesale of pharmaceutical goods
Accounts Submitted 30 Jun 2023
Confirmation Submitted 16 May 2022 Next due 23 May 2023 36 months overdue
Net assets £60K £836 2022 year on year
Total assets £63K £195 2022 year on year
Total Liabilities £2K £641 2022 year on year
Charges 1
1 outstanding

Contact & Details

Contact

Registered Address

The Octagon Suite E2, 2nd Floor Middleborough Colchester Essex CO1 1TG England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for MEDICINES BY DESIGN LTD (07870845), a dissolved company based in Colchester, England. Incorporated 5 Dec 2011. Wholesale of pharmaceutical goods. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2022
Type Total Exemption Full
Next accounts 31 December 2023
Due by 30 September 2024 9 months

Net Assets, Total Assets & Total Liabilities (2013–2022)

Cash in Bank

N/A

Net Assets

£60.25k

Decreased by £836.00 (-1%)

Total Liabilities

£2.34k

Increased by £641.00 (+38%)

Turnover

N/A

Employees

2

Debt Ratio

4%

Increased by 1 (+33%)

Financial History

Revenue, profit, EBITDA and key financial figures

2022
Dec Year End
2021
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Benjamin James GordonDirectorBritishEngland4516 Mar 2012Active

Shareholders

Shareholders (1)

Medicines By Design (holdings) Limited
100.0%
3

Persons with Significant Control

Persons with Significant Control (3)

3 Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Benjamin James Gordon

British

Active
Notified 6 Apr 2016
Residence England
DOB September 1980
Nature of Control
  • Significant Influence Or Control

Mr Kerry Hinton

English

Active
Notified 6 Apr 2016
Residence United Kingdom
DOB March 1971
Nature of Control
  • Significant Influence Or Control

Group Structure

Group Structure

MEDICINES BY DESIGN LTD Current Company

Charges

Charges

1 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
20 Feb 2024GazetteGazette Dissolved Compulsory
5 Dec 2023GazetteGazette Notice Compulsory
30 Jun 2023AccountsAnnual accounts made up to 2022-09-30
30 Jun 2023OfficersTermination of Kerry Hinton as director on 2023-06-08
16 May 2022Confirmation StatementConfirmation statement made on 2022-05-09 with no updates
20 Feb 2024 Gazette

Gazette Dissolved Compulsory

5 Dec 2023 Gazette

Gazette Notice Compulsory

30 Jun 2023 Accounts

Annual accounts made up to 2022-09-30

30 Jun 2023 Officers

Termination of Kerry Hinton as director on 2023-06-08

16 May 2022 Confirmation Statement

Confirmation statement made on 2022-05-09 with no updates

Recent Activity

Latest Activity

Gazette Dissolved Compulsory

2 years ago on 20 Feb 2024

Gazette Notice Compulsory

2 years ago on 5 Dec 2023

Annual accounts made up to 2022-09-30

2 years ago on 30 Jun 2023

Termination of Kerry Hinton as director on 2023-06-08

2 years ago on 30 Jun 2023

Confirmation statement made on 2022-05-09 with no updates

3 years ago on 16 May 2022